Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
TNXP
TNXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TNXP News
TONMYA Launches as New Treatment for Fibromyalgia
23h ago
Newsfilter
Life Sciences Virtual Investor Forum Agenda Announced
4h ago
Globenewswire
TONMYA Receives FDA Approval for Fibromyalgia Treatment
4d ago
Newsfilter
Tonix Pharmaceuticals to Present Tonmya at AAPM Annual Meeting
6d ago
Newsfilter
Tonix Pharmaceuticals Shares Decline Post Nasdaq Uplisting
Mar 03 2026
Benzinga
Tonix Pharmaceuticals Successfully Uplists to Nasdaq Global Select Market
Mar 03 2026
Globenewswire
Tonix Pharmaceuticals Successfully Uplists to Nasdaq Global Select Market
Mar 03 2026
Newsfilter
Tonix Pharmaceuticals Reports Positive Phase 3 Clinical Data for TONMYA
Jan 30 2026
NASDAQ.COM
TONMYA Shows Significant Pain Reduction in Fibromyalgia Treatment
Jan 30 2026
Newsfilter
Tonix Pharmaceuticals to Present at January 2026 Investor Conferences
Jan 06 2026
Globenewswire
Tonix Pharmaceuticals (TNXP) Enters $20M Securities Purchase Agreement with Point72
Dec 30 2025
Yahoo Finance
Tonix Pharmaceuticals Advances TNX-4800 for Lyme Disease with 2027 Testing Timeline
Dec 29 2025
Benzinga
Tonix Pharmaceuticals Enters $20M Stock Purchase Agreement with Point72 for 615,025 Shares
Dec 29 2025
Globenewswire
Tonix Pharmaceuticals Enters $20M Stock Purchase Agreement with Point72 for 615,025 Shares
Dec 29 2025
Newsfilter
Tonix Secures Exclusive Global Rights to TNX-4900, Advancing Non-Opioid Analgesic Development
Dec 16 2025
Globenewswire
Tonix Secures Exclusive Global Rights to TNX-4900, Advancing Non-Opioid Analgesic Development
Dec 16 2025
Newsfilter
Show More News
